Vaccine Ontology
1233 terms(s) returned
| Term Type: | Record: 1201 to 1233 of 1233 Records | Page: 25 of 25, First Previous Next Last | Show Records Per Page |
- human papillomavirus 9-valent vaccine
- human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension
- human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension [Cervarix]
- human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe
- human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Prefilled Syringe [Cervarix]
- human papillomavirus vaccine
- human parasite role
- human protein
- human rabies vaccine from Chicken fibroblast culture
- human respiratory syncytial virus
- human senior age range at vaccination
- human serum albumin
- human serum albumin vaccine additive
- human serum cell culture residual in vaccine
- human vaccinee
- human vaccinee at age 2-17 years old
- human vaccinee population
- human vaccinee population at age 2-17 years old
- human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension
- human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension [RotaTeq]
- human-bovine reassortant rotavirus strain G1 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G2 vaccine 1400000 UNT/ML / human-bovine reassortant rotavirus strain G3 vaccine 1100000 UNT/ML / human-bovine reassortant rotavirus strain G4 vaccine 1000000 UNT/ML / human-bovine reassortant rotavirus strain P1A[8] vaccine 1150000 UNT/ML Oral Suspension
- hyperacute - breast cancer vaccine
- hyperacute-melanoma vaccine
- hyperacute-prostate cancer vaccine
- hypersensitity to arginine
- hypersensitity to gelatin
- hypersensitivity to antibiotic
- hypersensitivity to chicken egg
- hypersensitivity to chicken product
- hypersensitivity to gentamicin
- hypersensitivity to neomycin
- hypersensitivity to polymyxin
- hypodermis
